Investigación / Grupos de investigación

Grupo  3

Enfermedades Sistémicas de Base Autoinmune

Publicaciones (396)

  • Nieto-Gonzalez, JC; Garulo, DC; Boteanu, A; Trives-Folguera, L; García-Fernández, A; Navarro, PG; Robledillo, JCL; Monteagudo-Saéz, I.

    What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

    JOURNAL OF RHEUMATOLOGY. 2023; 50(10): 1326-1332 Nº de citas: 2 [doi:10.3899/jrheum.2022-1305]

  • Michelsen, B; Ostergaard, M; Nissen, MJ; Ciurea, A; Moller, B; Ornbjerg, LM; Zavada, J; Glintborg, B; Macdonald, A; Laas, K; Nordstrom, D; Gudbjornsson, B; Iannone, F; Hellmand, P; Kvien, TK; Rodrigues, AM; Codreanu, C; Rotar, Z; Fernandez, IC; Wallman, JK; Vencovsky, J; Loft, AG; Heddle, M; Vorobjov, S; Hokkanen, AM; Groendal, G; Sebastiani, M; van de Sande, M; Kristianslund, EK; Santos, MJ; Mogosan, C; Tomsic, M; Diaz-Gonzalez, F; Di Giuseppe, D; Hetland, ML.

    Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    Lancet Regional Health-Europe. 2023; 33: Nº de citas: 2 [doi:10.1016/j.lanepe.2023.100706]

  • Linde, L; Ornbjerg, LM; Brahe, CH; Wallman, JK; Di Giuseppe, D; Závada, J; Castrejon, I; Díaz-Gonzalez, F; Rotar, Z; Tomsic, M; Glintborg, B; Gudbjornsson, B; Geirsson, AJ; Michelsen, B; Kristianslund, EK; Santos, MJ; Barcelos, A; Nordström, D; Eklund, KK; Ciurea, A; Nissen, M; Akar, S; Hyldstrup, LH; Krogh, NS; Hetland, ML; Ostergaard, M.

    Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    RHEUMATOLOGY. 2023; 63(7): 1882-1892 Nº de citas: 8 [doi:10.1093/rheumatology/kead494]

  • Exposito, L; Sanchez-Piedra, C; Vela-Casasempere, P; Moreno-Ramos, MJ; Campos, C; Bohorquez, C; Manero, J; Calvo-Gutierrez, J; Rodriguez-Lozano, C; Ruiz-Montesino, D; Busquets, N; Garcia-Gonzalez, J; Castrejon, I; Alonso, F; Bustabad, S; Diaz-Gonzalez, F.

    Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2023; 54(2): Nº de citas: 2 [doi:10.1111/eci.14095]

  • Mayordomo, L; Molina-Collada, J; Uson, J; Vivar, ML; Sturchio, GA; Corrales, A; Castillo-Gallego, C; Hernandez, F; Vicente-Rabaneda, EF; Nunez, FG; Gomez, I; Villar, M; Moragues, C; Corredor, D; de Miera, FJ; De Agustin, J; Molinero, MR; Sancho, JJ; Coronel, L; Huaranga, MA; Ruiz-Montesino, M; Collado-Ramos, P; Penas,M; Miguelez, R; Fernandez, E; Valera-Ribera, C; Naredo, E; ECOSER Grp.

    Ultrasonography in rheumatology: time to learn from patient views

    CLINICAL RHEUMATOLOGY. 2023; 42(12): 3341-3350 [doi:10.1007/s10067-023-06757-8]

  • Dejaco, C; Ramiro, S; Bond, M; Bosch, P; Ponte, C; Mackie, SL; Bley, TA; Blockmans, D; Brolin, S; Bolek, EC; Cassie, R; Cid, MC; Molina-Collada, J; Dasgupta, B; Nielsen, BD; De Miguel, E; Direskeneli, H; Duftner, C; Hocevar, A; Molto, A; Schafer, VS; Seitz, L; Slart, RHJA; Schmidt, WA.

    EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

    ANNALS OF THE RHEUMATIC DISEASES. 2023; 83(6): 741-751 Nº de citas: 171 [doi:10.1136/ard-2023-224543]

  • Molina-Collada, J; Castrejon, I; Monjo-Henry, I; Fernandez-Fernandez, E; Ortiz, GT; Martinez-Barrio, J; Alvaro-Gracia, JM; De Miguel, E.

    Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT

    Rmd Open. 2023; 9(3): Nº de citas: 7 [doi:10.1136/rmdopen-2023-003329]

  • Beltran, CD; Castrejon, I; Hernandez-Cruz, B; Vivar, MLG; de Vicunla, RG; Baures, MR; Carreira, P; Naredo, E; Reina, D; Galindo, M; Peralta, C; de Dios, BV; Carmona, L.

    Gender biases in Spanish rheumatology: Perception and facts

    Reumatologia Clinica. 2023; 19(7): 392-401 Nº de citas: 2 [doi:10.1016/j.reuma.2023.02.004]

  • Laino-Pineiro, MC; Rua-Figueroa, I; Jimenez, N; Lozano, MJC; Martinez-Barrio, J; Serrano, B; Galindo-Izquierdo, M; Nack, A; Loricera, J; Tomero-Muriel, E; Ibanez-Barcelo, M; Vazquez, NM; Manrique-Arija, S; Lorenzo, NA; Narvaez, J; Rosas, J; Menor-Almagro, R; Martinez-Taboada, VM; Aurrecoechea-Aguinaga, E; Horcada, L; Ruiz-Lucea, E; Raya, E; Toyos, FJ; Exposito, L; Vela, P; Freire-Gonzalez, M; Moriano-Morales, C; Bonilla-Hernan, G; Ibanez, TC; Lozano-Rivas, N; Moreno, M; Andreu, JL; Ubiaga, CLI; Torrente-Segarra, V; Valls, E; Velloso-Feijoo, ML; Alcazar, JL; Pego-Reigosa, J.

    Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 61: Nº de citas: 1 [doi:10.1016/j.semarthrit.2023.152232]

  • Pombo-Suarez, M; Seoane-Mato, D; Diaz-Gonzalez, F; Sanchez-Alonso, F; Sanchez-Jareno, M; Cea-Calvo, L; Castrejon, I.

    Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases

    Advances in Rheumatology. 2023; 63(1): Nº de citas: 1 [doi:10.1186/s42358-023-00296-1]

  • Bethencourt-Baute, JJ; Montero, N; Zacarias, AM; Nieto, JC; Lopez-Corbeto, M; Boteanu, A; Medrano, M; Rego, GDC; Vargas-Lebron, C; Machin-Garcia, S; Exposito, L; Cacheda, AP; Bernabeu, P; Veroz-Gonzalez, R; Fernandez, O; Merayo, EE; Torrente-Segarra, V; Fernandez-Alba, MD; Gamir, ML; Lopez-Robledillo, JC; Anton, J; Otero, L; Bustabad, S.

    Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry

    Reumatologia Clinica. 2023; 19(6): 328-333 [doi:10.1016/j.reuma.2023.01.002]

  • Valero, M; Sanchez-Piedra, C; Freire, M; Colazo, M; Busquets, N; Merino-Ibarra, E; Rodriguez-Lozano, C; Manrique, S; Campos, C; Sanchez-Alonso, F; Castrejon, I.

    Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry

    ARTHRITIS RESEARCH & THERAPY. 2023; 25(1): Nº de citas: 5 [doi:10.1186/s13075-023-03045-3]

  • Carpio Astudillo K; Montero Reyes F; Janta I; Molina Collada J; Anzola AM; Caballero Motta LR; Serrano-Benavente B; Martínez-Barrio J; Ariza Lapuente A; Rivera Redondo J; González-Fernández C; Monteagudo I; Álvaro-Gracia JM; Nieto-González JC.

    Salivary gland ultrasound in clinical practice: What is its real usefulness?

    Reumatologia Clinica. 2023; 19(5): 260-265 [doi:10.1016/j.reumae.2022.09.002]

  • Astudillo, KC; Reyes, FM; Janta, I; Collada, JM; Anzola, AM; Motta, LRC; Martinez-Barrio, J; Lapuente, AA; Redondo, JR; Gonzalez-Fernandez, C; Monteagudo, I; Alvaro-Gracia, JM; Nieto-Gonzalez, JC.

    Salivary gland ultrasound in clinical practice: What is its real usefulness?

    Reumatologia Clinica. 2023; 19(5): 260-265 Nº de citas: 1 [doi:10.1016/j.reuma.2022.09.005]

  • Muñoz A; Bautista-Molano W; Castrejón I; Hernández-Cruz B; Martín JM; Pinedo C; Urruticoechea A; Carmona L.

    Proposal for updating the Health Assessment Questionnaire.

    Reumatologia Clinica. 2023; 19(5): 266-272 [doi:10.1016/j.reumae.2022.08.001]

  • Molina-Collada, J; Castrejon, I; Rivera, J; Martinez-Barrio, J; Nieto-Gonzalez, JC; Lopez, K; Montero, F; Trives, L; Gonzalez, C; Alvaro-Gracia, JM.

    The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis

    Modern Rheumatology. 2023; 33(3): 549-556 Nº de citas: 9 [doi:10.1093/mr/roac058]

  • Trives-Folguera, L; Molina-Collada, J; Lopez, K; Rivera, J; Serrano-Benavente, B; Anzola-Alfaro, AM; Castrejon, I; Alvaro-Gracia, JM; Martinez-Barrio, J.

    Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study

    RHEUMATOLOGY INTERNATIONAL. 2023; 43(7): 1333-1340 Nº de citas: 2 [doi:10.1007/s00296-023-05321-6]

  • Molina-Collada, J; Castrejon, I; Monjo, I; Fernandez-Fernandez, E; Ortiz, GT; Alvaro-Gracia, JM; de Miguel, E.

    Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care

    Rmd Open. 2023; 9(2): Nº de citas: 10 [doi:10.1136/rmdopen-2022-002970]